ORBUSNEICH RECEIVES CE MARK APPROVAL FOR GENOUS, WORLD'S FIRST BIO-ENGINEERED STENT

OrbusNeich announced that it has received CE Mark (Conformite Europeenne) approval for its Genous Bio-engineered R stent. Genous is at the forefront of the accelerated natural healing approach to protect against thrombus and minimize restenosis. Genous promotes tissue healing to occur in a rapid and controlled manner at the stent injury, rather than inhibiting healing, including endothelial coverage, with potent antiproliferative drug eluting stents. Commercialization will be a controlled release in Europe and other international markets next month through an internet-based registry, e-HEALING.

Yahoo News (http://biz.yahoo.com/prnews/050822/flm011.html?.v=21)